Aardvark Therapeutics, Inc. Common Stock (NASDAQ: AARD) last traded at $1.33, down 12.50% on the session. The quote above updates while this page is open; the figures below are drawn from Aardvark Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Aardvark Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker AARD. Its market capitalisation is $29.12 million.
Valuation measures for Aardvark Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $29.12M |
|---|---|
| Enterprise value | -$24.03M |
| Price / book | 0.51 |
| Beta | 3.90 |
Trailing-twelve-month figures tagged in Aardvark Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$72.76M |
|---|
| EPS (TTM) | -$3.34 |
|---|
| Return on equity | -126.30% |
|---|
| Cash | $60.34M |
|---|
Range and volume for AARD over the past 52 weeks.
| 52-week high | $16.60 |
|---|---|
| 52-week low | $0.930 |
| Volume | 402.4K |
| Average volume | 617.7K |
| Previous close | $1.52 |
Invest a chosen dollar amount in Aardvark Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AARD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.